Glen Lo
Women's College Hospital
8 Papers
21 Citations
Glen Lo is an academic researcher from Women's College Hospital. The author has contributed to research in topics: Medicine & Axitinib. The author has an hindex of 5, co-authored 7 publications. Previous affiliations of Glen Lo include University Health Network & University of Toronto.
Chat about Author
Papers
Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging
Glen Lo,Anabel M. Scaranelo,Hana Aboras,Sandeep Ghai,Supriya Kulkarni,Rachel Fleming,Karina Bukhanov,Pavel Crystal +7 more
TL;DR: Contemporaneous screening mammography did not have added value in detection of breast cancer for women who undergo screening MR imaging, and routine use of screening Mammography in women undergoing screening breast MR imaging warrants reconsideration.
72
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma.
Mairéad G McNamara,Lisa W. Le,Anne M. Horgan,Alex Aspinall,Kelly W. Burak,Neesha C. Dhani,Eric Chen,Mehrdad Sinaei,Glen Lo,Tae Kyoung Kim,Patrik Rogalla,Oliver F. Bathe,Jennifer J. Knox +12 more
TL;DR: Second‐line treatment options in advanced hepatocellular carcinoma (HCC) are limited and a selective potent tyrosine kinase inhibitor of vascular endothelial growth factor VEGF receptors 1, 2, and 3, merits exploration in HCC.
52
Endometriosis: A multimodal imaging review.
J Quesada,Kirsi Hannele Härmä,Shannon Reid,T. Rao,Glen Lo,Natalie Yang,Sonal Karia,Emmeline Lee,Nira Borok +8 more
TL;DR: A detailed overview of the imaging features of endometriosis as well as the advances and usefulness of different imaging modalities for this condition can be found in this paper , which is based mostly on studies from the last two decades.
22
FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
Ur Metser,Glen Lo +1 more
TL;DR: The role of FDG-PET/CT in the diagnosis and staging of abdominal PTLD is discussed and the advantages of functional imaging in assessing response to therapy are described.
Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound.
Glen Lo,Glen Lo,Hassan Al Zahrani,Hyun-Jung Jang,Ravi Menezes,John M. Hudson,Peter N. Burns,Mairéad G McNamara,Mairéad G McNamara,Sonja Kandel,Korosh Khalili,Jennifer J. Knox,Patrik Rogalla,Tae Kyoung Kim +13 more
TL;DR: DCE-US is potentially useful in measuring early tumor response of advanced hepatocellular carcinoma to axitinib, but a larger trial is needed.
19